CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
Provided By GlobeNewswire
Last update: Nov 12, 2025
‒ Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million ‒
‒ Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million ‒
Read more at globenewswire.com9.98
-1.26 (-11.21%)
Find more stocks in the Stock Screener
CRMD Latest News and Analysis
6 days ago - By: Chartmill
7 days ago - By: Chartmill
